Stress, depression may be linked to harmful inflammation in Black pregnant women 

Study suggests Black pregnant individuals are more exposed to chronic social stressors that may increase their risk for negative health outcomes, racial disparities.

5:00 AM

Author | Beata Mostafavi

pregnancy lab notes
Michigan Medicine

Black individuals may be more likely to experience social stressors and depressive symptoms associated with inflammation during pregnancy, a new study suggests.

The findings, which appear in Brain, Behavior, & Immunity-Health, was based on a cohort of 187 pregnant Black women at prenatal clinics in the Midwest.

"Black women are more likely to experience systemic inflammation during pregnancy that is not only harmful to maternal health but can also affect health outcomes for babies later in life," said lead author Nadia Saadat, MBBS, M.S., Ph.D., a pediatrics research fellow at Michigan Medicine.

"We wanted to identify modifiable risk factors that could help reduce health disparities in maternal morbidity and mortality, and adverse birth outcomes among this population. Our findings suggest Black women are exposed to more chronic social stressors compared to other races, which may increase their risk for poor mental health and negatively affect reproductive health."

Inflammation is a normal part of the body's immune response to infection and injury, chronic stress or obesity. Heightened inflammation during pregnancy may increase risks for negative maternal and birth outcomes.

Studies have shown that social and environmental stressors can activate the stress response and trigger chronic inflammation affecting the whole body – a risk factor for poor cardiovascular health and mortality.

More than one in four pregnant people in the study reported depressive symptoms and depressive symptoms were found to be related to a marker of systemic inflammation. Intimate partner violence and other psychosocial risk factors such as smoking were also related to inflammation markers among participants.

Saadat says the data reinforces the need to develop new guidelines for healthcare providers to screen for social and behavioral risk factors and systemic inflammation, especially among high-risk population groups.

Previous research indicates that patients are more likely to take advantage of available treatment options during pregnancy when their providers recommend it.  

"Pregnant women should be screened for depressive symptoms by healthcare providers and encouraged to participate in programs to manage and treat depression," Saadat said.   

"Adequate screening for these risk factors and treating pregnant people for depression throughout pregnancy may be a critical intervention to improve overall maternal wellbeing and to reduce risk factors linked to racial disparities in pregnancy outcomes."

Additional authors include senior author Carmen Giurgescu of University of Central Florida; Liying Zhang of Wayne State University; Suzanne Hyer of University of Central Florida; Vasantha Padmanabhan of University of Michigan; Jennifer Woo of Texas Woman's University; Christopher Engeland of Pennsylvania State University and Dawn Misra of Michigan State University.

Study cited: "Psychosocial and behavioral factors affecting inflammation among pregnant African American women," Brain, Behavior, & Immunity-Health. DOI: 10.1016/j.bbih.2022.100452


More Articles About:

Lab Notes All Research Topics childbirth Pregnancy Labor Wellness and Prevention Community Health CS Mott Children's Hospital Von Voigtlander Women's Hospital Health Care Quality Race and Ethnicity Mental Health Assessment Pregnancy Complications obstetrics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Portrait of Peter Mourani, M.D., Professor and Associate Chair of Research for the Department of Pediatrics and Division Director of Pediatric Critical Care Medicine at Michigan Medicine and U-M Health C.S. Mott Children's Hospital.
News Release

U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
Graphic of parents stressed about bills
Health Lab

4 in 5 parents say having a baby is too expensive

Four in five parents say it costs too much to have a baby, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.